Venture Investors seeks the next big things in healthcare. Based in the Midwest with open access to renowned research universities, and the vibrant communities that surround them, we target, uncover, and invest in extraordinary ideas that will shape the future of health and wellness. With decades of proven success, we’re fueling the future of what’s driving healthcare. Today, we have over $200 million in assets under management.

Silatronix

Aerpio Pharmaceuticals

Cellectar Biosciences

Akebia Therapeutics

Celleration

ReShape Lifesciences

Third Wave Technologies

Virent Energy Systems

NeuMoDx Molecular

Neurovance

NeuWave Medical

Venture Investors

"We are delighted to have our pivotal trial fully enrolled with a total of 152 patients," said Tibor Juhasz, PhD, Founder and Chief Executive Officer, ViaLase, Inc..."Ultimately, it is our greatest wish to be able to provide an effective noninvasive treatment to the millions of people living with glaucoma, one of the leading causes of irreversible blindness worldwide."

Congratulations to Justin Mortara, Ph.D., Chris Fernandez, and the EnsoData team on this exciting partnership.

Great data from #Histosonics. Very safe and high techical success. Wonderful for patients. #ventureinvestors.

James (Jim) Adox, the chair of the board of directors of HistoSonics, Inc., will join the head of the U-M histotripsy research group and leaders from Michigan Medicine on the panel.

“Mammography alone is not enough to address the screening needs of dense breast patients,” said Mark J Forchette, president and CEO of Delphinus Medical Technologies. “SoftVue provides a comprehensive solution that enables providers to transform their patients’ clinical experience...and serve the unmet needs of patients with dense breast tissue that SoftVue was designed to address.” https://lnkd.in/g_4cubVi

"The round, oversubscribed and co-led by Flare Capital Partners and Frist Cressey Ventures, also saw participation from InHealth Ventures, Oxeon Partners, Pixel Perfect Ventures, Venture Investors, among others. Visana’s investors and the organizations they represent comprise over 30 of the nation’s leading healthcare organizations. They recognize that evidence-based, digital platforms like the one Visana offers are the best way to provide the comprehensive, clinical, and value-focused care women so desperately need." https://lnkd.in/eptEb4Ym

“Most women’s health solutions focus narrowly on maternity and fertility, missing the mark for the 90% of women who aren’t actively building a family,” said Shelly Lanning, co-founder and president, Visana. “We built Visana to provide women with in-depth care for all phases of life.”
https://lnkd.in/gvF3xger

Congrats to Erica Rogers on her well-deserved honor at this year's #MedtechMVP conference. And great job by James (Jim) Adox.

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

Google Font API

Google Analytics

WordPress

DoubleClick.Net

Managing Director

John Neis

Paul Weiss

Scott Button

Office Manager

Linda Olson

Investment Advisor

Erica J. Rogers

Executive Managing Director

James Adox

Finance and Administration

Jennifer Le

Business Management

Ken Hagerty

Robert McMahon

Winslow Sargeant

Tim Bartholow

Jeffrey Allen Bailey

Jim Adox

David Arnstein

Chief Financial Officer and Managing Director

Becky Hoerman

Controller

Jake Simon

Principal Venture Partner

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

Cellectar Biosciences is a pharmaceutical research company specializing in cancer drugs.

ReShape Lifesciences is a developer of medical devices to treat obesity and metabolic diseases.

NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing

NeuWave Medical develops energy-based minimally invasive medical devices to treat a variety of serious medical conditions.

Silatronix develops organosilicon electrolytes for energy storage devices such as ultracapacitors and lithium-ion batteries.

Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD.

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

Virent Energy Systems is an energy technology company providing solutions that facilitate the renewable replacement of fossil fuels.

LensX Lasers is a developer of surgical lasers used for the reparation of cataracts.

Venture Stage Investors with Investments in Ohio

Late Stage Venture Investors with Investments in Western US

Late Stage Venture Investors Venture Capital Investors

Midwestern US Late Stage Venture Investors

Turning innovation into health. Venture Investors seeks the next big things in healthcare. Based in the Midwest with open access to renowned research universities, and the vibrant communities that surround them, we target, uncover, and invest in extraordinary ideas that will shape the future of health and wellness. With decades of proven success, we’re fueling the future of what’s driving healthcare. Today, we have over $200 million in assets under management.

Venture Investors Health Fund VI

Venture Investors Health Fund 6 Limited Partnership

Venture Investors Early Stage Fund V

Venture Investors Early Stage Fund IV

Venture Investors Early Stage Fund III

Advantage Capital Wisconsin Partners I

Venture Investors Early Stage Fund II

Venture Investors of Wisconsin

Madison

Wisconsin

United States

North America

5 Interesting Startup Deals You May Have Missed In April: Firefighting Robots And Animal-Free Eggs

Venture Investors Invests in EarliTech

HistoSonics Nabs $85M For Device To ‘Liquify’ Tumors

Bangladesh

Asia

India

Pakistan

Rock Health is a venture capital firm focused on investing in innovative healthcare technology startups.

Rock Health

Healthy Ventures is a venture capital firm specializing in funding early-stage companies in the healthcare technology sector.

Healthy Ventures

Virtue VC is a venture capital firm that actively invests in healthcare technology companies, particularly those focused on digital therapeutics and innovative healthcare solutions.

Virtue VC

Lerer Hippeau is a venture capital firm that has shown interest in investing in healthcare technology startups, particularly those with innovative solutions in the digital health space.

Lerer Hippeau

Looking Glass Capital is a venture capital firm that focuses on funding companies in the healthcare technology sector, with a particular interest in digital therapeutics and health tech innovations.

Looking Glass Capital

RH Capital is a venture capital firm that has demonstrated a commitment to investing in healthcare technology companies, particularly those involved in digital therapeutics and digital health solutions.

RH Capital

Flare Capital is a venture capital firm specializing in funding innovative healthcare technology startups, with a focus on digital therapeutics and transformative health tech solutions.

Flare Capital

Susa Ventures is a venture capital firm that has shown interest in investing in healthcare technology startups, particularly those with innovative solutions in the digital health space.

Susa Ventures

Lux Capital is a venture capital firm that actively invests in healthcare technology companies, particularly those focused on digital therapeutics and innovative healthcare solutions.

Lux Capital

General Catalyst is a venture capital firm that has demonstrated a commitment to investing in healthcare technology companies, particularly those involved in digital therapeutics and digital health solutions.

General Catalyst

Define Ventures is a venture capital firm focused on investing in innovative healthcare technology startups, particularly in the digital therapeutics and health tech sectors.

Define Ventures

Venture Investors is a venture capital firm that specializes in funding innovative startups, particularly in the healthcare and technology sectors. The firm has a history of investing in early-stage companies and helping them grow through strategic investments and guidance.

news impact assignment basic	general
public peers	general	May 10, 2024 4:10 PM	be6d337e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	dcfa9fe9
crunchbase profile	general	Nov 25, 2024 9:48 AM	c3f45a3e
li profile	general	May 10, 2024 4:10 PM	a23d103b
translate crunchbase fundingrounds	general	Nov 25, 2024 2:05 PM	ffbde7b4
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:VENTUREINVESTORS

Venture Investors